Key statistics
On Thursday, Twist Bioscience Corp (0ME:FRA) closed at 39.61, -25.55% below its 52-week high of 53.20, set on Jul 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.28 |
---|---|
High | 39.61 |
Low | 38.21 |
Bid | 38.96 |
Offer | 40.51 |
Previous close | 38.06 |
Average volume | 180.56 |
---|---|
Shares outstanding | 59.36m |
Free float | 58.22m |
P/E (TTM) | -- |
Market cap | 2.44bn USD |
EPS (TTM) | -3.60 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 20:16 GMT.
More ▼
Press releases
- Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
- Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
- Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
- Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
- Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
- Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
- Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
- Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
- Twist Bioscience to Present at Baird Global Healthcare Conference 2024
More ▼